Novo Nordisk's pricing approaches inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of cost gouging, declaring the stark contrast in between U.S. price ranges and people in Europe and copyright. Complications with diabetic re